adx-629
Showing 1 - 7 of 7
Sjogren-Larsson Syndrome Trial in Omaha (ADX-629)
Recruiting
- Sjogren-Larsson Syndrome
- ADX-629
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Nov 7, 2022
Ethanol Intoxication Trial in Cincinnati (ADX-629, Placebo)
Recruiting
- Ethanol Intoxication
- ADX-629
- Placebo
-
Cincinnati, OhioMedpace Clinical Pharmacology
Aug 2, 2022
Atopic Asthma Trial in Mississauga (ADX-629, Placebo)
Completed
- Atopic Asthma
- ADX-629
- Placebo
-
Mississauga, Ontario, CanadaCliantha Research
Jan 9, 2023
Covid19 Trial in Miami (ADX-629, Placebo)
Completed
- Covid19
- ADX-629
- Placebo
-
Miami, FloridaMedical Research Center of Miami II, Inc.
Sep 26, 2022
Plaque Psoriasis Trial in San Diego (ADX-629)
Completed
- Plaque Psoriasis
- ADX-629
-
San Diego, CaliforniaTCR Medical Corporation
May 5, 2022
Nephrotic Syndrome Trial in United States (ADX-629)
Not yet recruiting
- Nephrotic Syndrome
- ADX-629
-
Northridge, California
- +10 more
Jan 24, 2023
Chronic Cough Trial in United States (ADX-629, Placebo)
Recruiting
- Chronic Cough
- ADX-629
- Placebo
-
San Diego, California
- +13 more
Sep 21, 2022